Application 021018

Type
BLA
Sponsor
LILLY

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
021018Humalog Mix 50/50insulin lispro protamine and insulin lispro351(a)Disc2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HUMALOG MIX 50/50INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANTINJECTABLE;INJECTION50 UNITS/ML;50 UNITS/MLNoNo
002HUMALOG MIX 50/50 KWIKPENINSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANTINJECTABLE;INJECTION50 UNITS/ML;50 UNITS/MLNoNo
003HUMALOG MIX 50/50 PENINSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANTINJECTABLE;INJECTION50 UNITS/ML;50 UNITS/MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Humalog Mix50/50 KwikPenINSULIN LISPROEli Lilly and Companyb34cd3ff-d0af-4852-b4ef-2a8b4a93aeae2026-01-13Warnings, Adverse reactionsExact identifier
application number: BLA021018
ndc (product): 0002-8798
ndc (product): 0002-7512

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 16 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0002-7512HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyBLACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyBLACurrent
0002-7512HumalogInsulin lisproEli Lilly and CompanyBLACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyNDACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyBLACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyBLACurrent
0002-8798HumalogInsulin lisproEli Lilly and CompanyBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74878SUPPL 2023-07-24
74872SUPPL 2023-07-24
66379APPL2020-03-23
60947SUPPL2020-03-23
60946SUPPL2020-03-23
60880SUPPL2020-03-23
60879SUPPL2020-03-23
57667SUPPL2020-03-23
55757SUPPL2020-03-23
55756SUPPL2020-03-23
55627SUPPL2020-03-23
55626SUPPL2020-03-23
46789SUPPL2020-03-23
46763SUPPL2020-03-23
41881ORIG2020-03-23
35910SUPPL2020-03-23
35909SUPPL2020-03-23
35908SUPPL2020-03-23
35907SUPPL2020-03-23
35906SUPPL2020-03-23
35905SUPPL2020-03-23
26513SUPPL2020-03-23
26512SUPPL2020-03-23
26511SUPPL2020-03-23
26510SUPPL2020-03-23
26509SUPPL2020-03-23
26508SUPPL2020-03-23
26507SUPPL2020-03-23
26506ORIG2020-03-23
14189SUPPL2020-03-23
14188SUPPL2020-03-23
14187ORIG2020-03-23
4072SUPPL2020-03-23
4071SUPPL2020-03-23